Frontlight ResearchEarly access
Trial site
Hospital Universitario Dr. Peset
- 5running trials
- 4closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease4 trials
- Diffuse large B-cell lymphoma1 trial
- Lung cancer1 trial
- Mantle cell lymphoma1 trial
- Metastatic breast cancer1 trial
- Mild cognitive impairment1 trial
- Parkinson disease1 trial
- Phase
- Phase 25 trials
- Phase 34 trials
- Status
- Active, not recruiting3 trials
- Terminated3 trials
- Recruiting2 trials
- Completed1 trial
- Suspended1 trial
- Lead sponsor
- Biogen2 trials
- Hoffmann-La Roche2 trials
- Amgen1 trial
- Eagle Pharmaceuticals, Inc.1 trial
- Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea1 trial
- and 3 more
Running trials
Recruiting
Active, not recruiting
Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab)
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Diffuse large B-cell lymphoma1 recruiting
- Metastatic breast cancer1 recruiting
Closed trials
Terminated
A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease
Terminated
Terminated
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026